Vitrolife AB (publ) (STO:VITR)

Market Cap	20.06B
Revenue (ttm)	3.54B
Net Income (ttm)	455.00M
Shares Out	135.42M
EPS (ttm)	3.35
PE Ratio	44.20
Forward PE	34.09
Dividend	1.10 (0.74%)
Ex-Dividend Date	Apr 30, 2025

Volume	47,883
Average Volume	134,344
Open	147.30
Previous Close	147.30
Day's Range	146.10 - 148.30
52-Week Range	133.30 - 268.00
Beta	1.79
RSI	54.75
Earnings Date	Jul 17, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,169
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: VITR